-
Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer.
Baka S, Califano R, Ferraldeschi R, Aschroft L, Thatcher N, Taylor P, Faivre-Finn C, Blackhall F, Lorigan P.
Br J Cancer. 2008 Aug 5; 99(3):442-7.
[Br J Cancer. 2008]
-
A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer.
Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dagg K, Scott HR.
Br J Cancer. 2005 May 23; 92(10):1834-6.
[Br J Cancer. 2005]
-
Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer.
Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ.
Br J Cancer. 2004 May 4; 90(9):1704-6.
[Br J Cancer. 2004]
- » See all...